Ketamine for treatment-resistant depression: Ready or not for clinical use?
10.1176/appi.ajp.2013.13081034
Saved in:
Main Author: | John Rush, A. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Editorial |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110669 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A STUDY OF DEPRESSION AND THE ANTIDEPRESSANT EFFECTS OF KETAMINE FROM AN IMMUNOINFLAMMATORY PERSPECTIVE
by: JOHNSON FAM
Published: (2020) -
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence
by: Nelson Rodrigues, et al.
Published: (2020) -
Improving the prediction of treatment response in depression: Integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures
by: Kemp, A.H., et al.
Published: (2014) -
Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression
by: Kumar, A., et al.
Published: (2021) -
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: Results of the NIMH star*D trial
by: Friedman, E.S., et al.
Published: (2014)